Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma
ConditionBleomycin Adverse Reaction
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-12
SponsorAssiut University
About this trial
Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :
* Clinically based on Change in the Size and Color of Hemangioma. * Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology . * Comparison of Complications associated with Bleomycin and Diode Laser.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age between 3 Months and 1 Year old.
Non Complicated Infantile Hemangioma
Disqualifiers
Younger than 3 Months or older than 1 Year.
Complicated Infantile Hemangioma
Trial population
Comparative Study Between Effect of Bleomycin Intralesional Injection And Application of Diode Laser on Infantile Hemangioma .
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Diode laser
DeviceApplication of laser waves on the lesion
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Group A0 interventions
Group B: Group b1 intervention
Trial outcomes
Primary outcomes
1
Effect of diode laser on hemangioma
Time frame
3 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: